ONY Biotech is a family-focused neonatology pharmaceutical company creating therapies that improve outcomes for premature babies and their families.
About us
Helping babies breathe since 1998.
For babies with respiratory distress syndrome, tomorrow is made possible by Infasurf® (calfactant).
Infasurf® (calfactant) helps prevent and treat respiratory distress syndrome in newborns, restoring surface activity in the lungs and quickly improving respiration.
Learn moreLatest News
Honoring ONY’s founder, Dr. Edmund Egan
October 21, 2022
Earlier this year, our founder and longtime Chief Medical Officer, Dr. Edmund Egan—known by many as Ted—announced his retirement...
Study Results are in on a Potential Non-Invasive Treatment for RDS
November 3, 2020
STUDY RESULTS ARE IN ON A POTENTIAL NON-INVASIVE TREATMENT FOR RDS, THE LEADING CAUSE OF DEATH IN PREMATURE BABIES...
ONY BIOTECH PREPARES FOR THE FUTURE
May 19, 2020
Dr. James Cummings has been an unofficial member of the ONY Biotech family since 1989, when he first started...